Redpoint Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.72M | Sell |
5,950
-1,031
| -15% | -$299K | 0.25% | 95 |
|
|
2022
Q2 | $1.97M | Sell |
6,981
-75
| -1% | -$21.1K | 0.23% | 98 |
|
|
2022
Q1 | $1.84M | Sell |
7,056
-131
| -2% | -$34.2K | 0.18% | 127 |
|
|
2021
Q4 | $1.58M | Hold |
7,187
| – | – | 0.13% | 189 |
|
|
2021
Q3 | $1.3M | Sell |
7,187
-141
| -2% | -$25.6K | 0.11% | 212 |
|
|
2021
Q2 | $1.48M | Buy |
7,328
+101
| +1% | +$20.4K | 0.12% | 207 |
|
|
2021
Q1 | $1.55M | Buy |
7,227
+468
| +7% | +$101K | 0.13% | 183 |
|
|
2020
Q4 | $1.6M | Sell |
6,759
-456
| -6% | -$108K | 0.16% | 154 |
|
|
2020
Q3 | $1.96M | Sell |
7,215
-12,000
| -62% | -$3.26M | 0.21% | 111 |
|
|
2020
Q2 | $5.58M | Sell |
19,215
-1,414
| -7% | -$410K | 0.31% | 73 |
|
|
2020
Q1 | $4.91M | Sell |
20,629
-167
| -0.8% | -$39.7K | 0.31% | 77 |
|
|
2019
Q4 | $4.55M | Sell |
20,796
-618
| -3% | -$135K | 0.22% | 114 |
|
|
2019
Q3 | $3.63M | Sell |
21,414
-380
| -2% | -$64.4K | 0.19% | 135 |
|
|
2019
Q2 | $4M | Sell |
21,794
-288
| -1% | -$52.8K | 0.21% | 118 |
|
|
2019
Q1 | $4.06M | Buy |
22,082
+1,119
| +5% | +$206K | 0.2% | 124 |
|
|
2018
Q4 | $3.47M | Hold |
20,963
| – | – | 0.2% | 130 |
|
|
2018
Q3 | $4.04M | Hold |
20,963
| – | – | 0.2% | 123 |
|
|
2018
Q2 | $3.56M | Buy |
20,963
+469
| +2% | +$79.7K | 0.19% | 140 |
|
|
2018
Q1 | $3.34M | Hold |
20,494
| – | – | 0.19% | 152 |
|
|
2017
Q4 | $3.07M | Buy |
+20,494
| New | +$3.07M | 0.17% | 168 |
|